Patient perspectives following pharmacogenomics results disclosure in an integrated health system.

AIM

To assess patient perceptions and utilization of pharmacogenomics (PGx) testing in an integrated community health system.

METHODS

Fifty-seven patients completed an online survey assessing their experiences with PGx testing offered through two methods: a designated PGx clinic or direct access in-home testing.

RESULTS

The majority of participants perceived PGx testing as helpful in their healthcare and reported understanding their results. Some had concerns about privacy and discrimination; most lacked familiarity with the Genetic Information Nondiscrimination Act. There were no significant differences in views between participants tested through either model.

CONCLUSION

Participants reported value in both methods of PGx testing. Patient experiences, understanding and result utilization will play an important role in informing future development and implementation of PGx programs.